Matching articles for "Rosiver"
Issue 1695 · February 5, 2024
Drugs for Rosacea

Rosacea is a common, chronic inflammatory facial eruption of unknown cause. It is more prevalent in women than in men, and disease onset typically occurs after age 30. Rosacea is characterized by erythema,…

Med Lett Drugs Ther. 2024 Feb 5; 66(1695):21-2 doi:10.58347/tml.2024.1695b
Rosacea is a common, chronic inflammatory facial eruption of unknown cause. It is more prevalent in women than in men, and disease onset typically occurs after age 30. Rosacea is characterized by erythema, telangiectasia, and flushing, and sometimes by recurrent, progressive crops of acneiform papules and pustules, usually on the central part of the face. Some patients develop granulomas and tissue hypertrophy, which may lead to rhinophyma (a bulbous nose), particularly in men. Blepharitis and conjunctivitis are common. Keratitis and corneal scarring occur rarely.
Issue 1679 · June 26, 2023 Free
In Brief: OTC Ivermectin for Head Lice

Topical ivermectin lotion 0.5% (Sklice, and generics), which has been available by prescription since 2012, is now FDA-approved for sale over the counter (OTC) for treatment of head lice in patients ≥6…

Med Lett Drugs Ther. 2023 Jun 26; 65(1679):103-4 doi:10.58347/tml.2023.1679e
Topical ivermectin lotion 0.5% (Sklice, and generics), which has been available by prescription since 2012, is now FDA-approved for sale over the counter (OTC) for treatment of head lice in patients ≥6 months old. Ivermectin is also available by prescription as a 1% cream (Soolantra) approved for topical treatment of inflammatory lesions of rosacea and in oral tablets ( Stromectol , and generics) for treatment of various parasitic infections.
Issue 1669 · February 6, 2023
Epsolay - A Benzoyl Peroxide Cream for Rosacea

Epsolay (Galderma), a 5% benzoyl peroxide cream, has been approved by the FDA for treatment of inflammatory lesions of rosacea in adults. It is the first product containing benzoyl peroxide to be approved in…

Med Lett Drugs Ther. 2023 Feb 6; 65(1669):21-2 doi:10.58347/tml.2023.1669c
Epsolay (Galderma), a 5% benzoyl peroxide cream, has been approved by the FDA for treatment of inflammatory lesions of rosacea in adults. It is the first product containing benzoyl peroxide to be approved in the US for treatment of rosacea. Benzoyl peroxide formulations approved for acne have been used off-label to treat rosacea for years, but itching and burning have limited their use.
Issue 1611 · November 16, 2020
Minocycline Foam (Zilxi) for Rosacea

The FDA has approved a 1.5% topical foam formulation of minocycline ( Zilxi – Foamix) for treatment of inflammatory lesions of rosacea in adults. It is the only topical minocycline product approved for this…

Med Lett Drugs Ther. 2020 Nov 16; 62(1611):179-80
The FDA has approved a 1.5% topical foam formulation of minocycline ( Zilxi – Foamix) for treatment of inflammatory lesions of rosacea in adults. It is the only topical minocycline product approved for this indication. The same manufacturer markets minocycline foam 4% (Amzeeq) for treatment of acne in patients ≥9 years old.
Issue 1521 · May 22, 2017
Oxymetazoline Cream (Rhofade) for Rosacea

The FDA has approved the selective alpha 1A -adrenergic receptor agonist oxymetazoline as a 1% cream ( Rhofade – Allergan) for topical treatment of persistent facial erythema of rosacea in adults.…

Med Lett Drugs Ther. 2017 May 22; 59(1521):84-6
The FDA has approved the selective alpha 1A -adrenergic receptor agonist oxymetazoline as a 1% cream ( Rhofade – Allergan) for topical treatment of persistent facial erythema of rosacea in adults. Brimonidine, a selective alpha 2 -adrenergic receptor agonist, was approved in 2013 as a 0.33% gel ( Mirvaso) for the same indication. Like Mirvaso , Rhofade is not indicated for treatment of inflammatory lesions of rosacea. Oxymetazoline has been available over the counter for many years as a nasal decongestant spray ( Afrin , and others).
Issue 1487 · February 1, 2016
Drugs for Rosacea

This common, chronic inflammatory facial eruption of unknown cause is more prevalent in women than in men. Rosacea is characterized by erythema and telangiectasia, and sometimes by recurrent, progressive crops…

Med Lett Drugs Ther. 2016 Feb 1; 58(1487):16-7
This common, chronic inflammatory facial eruption of unknown cause is more prevalent in women than in men. Rosacea is characterized by erythema and telangiectasia, and sometimes by recurrent, progressive crops of acneiform papules and pustules, usually on the central part of the face. Some patients develop granulomas and tissue hypertrophy, which may lead to rhinophyma (a bulbous nose), particularly in men. Blepharitis and conjunctivitis are common. Keratitis and corneal scarring occur rarely.